BIO-PATH HOLDINGS, INC. (BPTH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 15K 30K 45K Q1 '13: 0 Q2 '13: 0 Q3 '13: 0 Q4 '13: 0 Q1 '14: 0 Q2 '14: 0 Q3 '14: 0 Q4 '14: 0 Q1 '15: 0 Q2 '15: 0 Q3 '15: 0 Q4 '15: 0 Q1 '16: 0 Q2 '16: 0 Q3 '16: 0 Q4 '16: 13K Q1 '17: 0 Q2 '17: 0 Q3 '17: 0 Q4 '17: 37K Q2 '13 Q1 '14 Q4 '14 Q3 '15 Q2 '16 Q1 '17 Q4 '17

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-6M -4M -2M 0 2M 4M 6M Q1 '21: -2.4M Q2 '21: -1.8M Q3 '21: -2.1M Q4 '21: -4.1M Q1 '22: -3.4M Q2 '22: -3M Q3 '22: -3.5M Q4 '22: -4M Q1 '23: -5.3M Q2 '23: -4.2M Q3 '23: -3.3M Q4 '23: -3M Q1 '24: -3.7M Q2 '24: -3M Q3 '24: -2.6M Q4 '24: -2.6M Q1 '25: -3.2M Q2 '25: -4.6M Q3 '25: -488K Q1 '26: -297K Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q1 '26

Net Income Quarterly

-6M -4M -2M 0 2M 4M 6M Q1 '21: -2.4M Q2 '21: -1.8M Q3 '21: -2.1M Q4 '21: -4.1M Q1 '22: -3.4M Q2 '22: -3M Q3 '22: -3.5M Q4 '22: -4M Q1 '23: -5.3M Q2 '23: -4.2M Q3 '23: -3.2M Q4 '23: -3.4M Q1 '24: -3.2M Q2 '24: -1.9M Q3 '24: -2.1M Q4 '24: -2.8M Q1 '25: -2.9M Q2 '25: -4.6M Q3 '25: -976K Q1 '26: -270K Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q1 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q1 '21: -1.6M Q2 '21: -2.7M Q3 '21: -2.9M Q4 '21: -2.8M Q1 '22: -2.5M Q2 '22: -4.2M Q3 '22: -3.4M Q4 '22: -5M Q1 '23: -3.7M Q2 '23: -3.3M Q3 '23: -2.8M Q4 '23: -1.8M Q1 '24: -1M Q2 '24: -4.3M Q3 '24: -3.4M Q4 '24: -2.9M Q1 '25: -1.3M Q2 '25: -283K Q3 '25: 0 Q1 '26: -38K Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q1 '26

Free Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q1 '16: -2.4M Q2 '16: -2.2M Q3 '16: -1.9M Q4 '16: -1.9M Q1 '17: -2.3M Q2 '17: -2.5M Q3 '17: -1.5M Q4 '17: -2.2M Q1 '18: -1.7M Q2 '18: -1.7M Q3 '18: -1.5M Q4 '18: -1.3M Q1 '19: -2M Q2 '19: -2.2M Q3 '19: -1.9M Q4 '19: -2.2M Q3 '21: -2.9M Q4 '21: -2.8M Q3 '22: -3.4M Q4 '22: -5M Q2 '16 Q1 '17 Q4 '17 Q3 '18 Q2 '19 Q3 '21 Q4 '22

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 3.5M 7M 10.5M Q1 '21: 5.7M Q2 '21: 7M Q3 '21: 7M Q1 '22: 7.2M Q2 '22: 7.2M Q3 '22: 7.2M Q1 '23: 398K Q2 '23: 398K Q3 '23: 503K Q1 '24: 647K Q2 '24: 1.6M Q3 '24: 3M Q1 '25: 7.1M Q2 '25: 8.3M Q3 '25: 8.5M Q1 '26: 9.3M Q2 '21 Q1 '22 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-75.00 -50.00 -25.00 0.00 25.00 50.00 75.00 Q4 '20: -2.82 Q1 '21: -2.35 Q2 '21: -2.06 Q3 '21: -1.55 Q4 '21: -1.57 Q1 '22: -1.61 Q2 '22: -1.77 Q3 '22: -1.97 Q4 '22: -38.12 Q1 '23: -50.90 Q2 '23: -61.12 Q3 '23: -66.99 Q4 '23: -34.54 Q1 '24: -26.17 Q2 '24: -16.69 Q3 '24: -11.03 Q4 '24: -4.12 Q1 '25: 0.36 Q2 '25: 0.97 Q3 '25: 1.56 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.